ArticleThe Laryngoscope2026
Alveolar Extracellular Vesicles May Protect Some Patients With Chronic Aspiration From Pneumonia.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Alveolar Extracellular Vesicles May Protect Some Patients With Chronic Aspiration From Pneumonia.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivesAspiration pneumonia (PNA) is a significant cause of morbidity and mortality. Up to 30% of healthy older adults may aspirate; however, many individuals with chronic aspiration do not develop PNA. We hypothesize that some patients with chronic aspiration may have distinct immune profiles that protect against PNA.
methodsWe prospectively enrolled 23 adults with profound swallowing impairment and objective evidence of chronic aspiration, and 5 controls without aspiration. All patients underwent bronchoalveolar lavage. Samples were analyzed for pH, cytokines, and markers of immune cell function. Extracellular vesicles (EVs) were isolated from alveolar fluid by ultracentrifugation, and EV protein composition was analyzed by mass spectrometry.
resultsOf 23 chronic aspirators (median age 63 [61-69], 87% male), 14 (61%) had no PNA and 9 (39%) had ≥ 1 PNA in 2 years. There was no difference in the penetration-aspiration score, patient-reported outcome scores, markers of inflammation, neutrophil function, or pH in the alveolar fluid between groups. Compared to chronic aspirators without PNAs, those with PNAs had a significantly higher alveolar EV concentration (5.6 × 10
conclusionsPatients with chronic aspiration who are not prone to developing pneumonia exhibit a distinct alveolar immune phenotype which may be protective against lung injury. These extracellular-mediated pathways may serve as future diagnostic and therapeutic targets. LEVEL OF EVIDENCE: Level 3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.